COSMO PHARMACEUTICALS
Updates & Highlights
StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data
StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data - Read more on Genetic Engineering and Biotechnol...
Genetic Engineering and Biotechnology News · 3 months ago
Hair loss drug succeeds in Phase 3, but data underwhelms experts
Hair loss drug succeeds in Phase 3, but data underwhelms experts - Read more on statnews.com
statnews.com · 4 months ago
Is It Too Late To Consider Cosmo Pharmaceuticals (SWX:COPN) After A 75% One Year Surge?
Is It Too Late To Consider Cosmo Pharmaceuticals (SWX:COPN) After A 75% One Year Surge? - Read more on Yahoo Finance
Yahoo Finance · 9 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Team information coming soon